Zurko Research
Zurko Research is a Spain-based Contract Research Organization specializing in in vivo and in vitro clinical testing and regulatory consultancy for cosmetic manufacturers, medical device companies, and biocide firms across EU and US markets.
- Company typePrivate
- Founded2005
- HeadquartersMadrid, Spain
- Headcount51–100
- GTM typeB2B
- OfferingServices
Zurko Research firmographics
Firmographics- Name
- Zurko Research
- Legal name
- ZURKO RESEARCH SL
- Website
- https://zurkoresearch.com
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Zurko Research is a Spain-based Contract Research Organization specializing in in vivo and in vitro clinical testing and regulatory consultancy for cosmetic manufacturers, medical device companies, and biocide firms across EU and US markets.
- Ownership category
- akta.pro rank
Zurko Research industry classification
Industry- Product category
- Contract Research Organization (CRO)
- NAICS
- Scientific Research and Development Services (5417), Testing Laboratories and Services (54138), Other Scientific and Technical Consulting Services (541690)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)
- akta.pro primary industry
- Toxicology & Safety Assessment CROs (GLP) (HLAGAAAC)
- akta.pro secondary industries
- Clinical CROs (Phase I–IV) (HLAGAAAA), Medical Writing & Regulatory Submission Support CROs (HLAGAAAG), Pharmacovigilance, Risk Management & Medical Affairs CROs (HLAGAAAH)
Keywords
Where Zurko Research is headquartered
LocationHeadquarters
- HQ city
- Madrid
- HQ country
- Spain
- HQ region
- Europe
Offices5 records
Markets served
Zurko Research business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Clinical Testing Services: In vivo and in vitro safety and efficacy testing services for cosmetic products, medical devices, and biocides. Includes HRIPT/RIPT testing, SPF testing, patch testing, challenge tests, and clinical efficacy studies.
- Regulatory Consulting: Technical, legal, and regulatory consultancy for medical device CE marking, quality management systems (ISO 13485), product dossiers, and facility licensing. Also covers cosmetics regulatory support for EU and international markets.
- Preclinical Testing: Biocompatibility testing (ISO 10993 series), including cytotoxicity, sensitization, irritation, acute toxicity, genotoxicity, hemocompatibility, and pyrogenicity testing. Also includes stability studies and antimicrobial efficacy testing.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
Zurko Research product offering
Product offeringCore offering
Zurko Research is a Contract Research Organization (CRO) providing clinical testing and regulatory consultancy services for the cosmetics, medical devices, and biocides industries. Core offerings include in vivo and in vitro safety testing (HRIPT/RIPT, patch tests, challenge tests), clinical efficacy studies, preclinical biocompatibility testing per ISO 10993, and regulatory services covering CE marking, ISO 13485 quality systems, FDA submissions, and EU/international cosmetics compliance.
Product overview
Zurko Research is a Contract Research Organization (CRO) established in 2005, specializing in clinical and in vitro testing of cosmetic products and medical devices. The company operates three integrated service lines: (1) Cosmetics Testing comprising in vivo safety testing (HRIPT/RIPT, patch tests, in-use studies), in vitro safety testing (preservative efficacy, HET-CAM), and clinical efficacy testing for skincare, makeup, haircare, sunscreen, oral care, and sensory evaluation; (2) Medical Device Services covering preclinical biocompatibility testing (ISO 10993), clinical studies, regulatory affairs (CE marking, FDA submissions), and quality systems (ISO 13485); and (3) the acquired Centro de Tecnología Capilar (CTC) for specialized haircare and scalp testing. Services are delivered through company-owned facilities in Madrid and Albacete (Spain), Barcelona (haircare lab), and New York (USA), supported by a panelist database of over 16,000 volunteers and more than 70 professionals. Online ordering is available through an Odoo-based portal.
Differentiator
Problem solved
Functional benefit
Brands
- Club Zurko: Panelist club website for volunteer recruitment and management, accessible at www.clubzurko.com
- Centro de Tecnología Capilar (CTC)
Products and services
- In Vivo Safety Testing
- In Vitro Safety Testing
- Clinical Efficacy Testing
- HRIPT/RIPT Testing Service
- Preclinical Testing Services
- Clinical Studies for Medical Devices
- Medical Device Regulatory Services
- Cosmetics Regulatory Services
- Sunscreen & Solar Protection Testing
- Hair Care Efficacy Testing (CTC)
Quantifiable outcome
- Study reports delivered within 10 business days maximum
- +2 more outcomes
Companies that use Zurko Research
Customer profileSegments3 records
Ideal customer profiles3 records
Zurko Research technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Zurko Research partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Centro de Tecnología Capilar (CTC)coreCTC was founded in Barcelona in 1995 as a specialized hair and scalp research center. In 2021, CTC became part of Zurko Research, expanding the company's capabilities in haircare efficacy testing for scalp, nails, eyebrows, eyelashes, beard, and body hair products. CTC brings expertise in in vitro and ex vivo testing for hair care products.
Scale indicators6 records
Recent moves8 records
Expansion highlights6 records
Zurko Research competitors and assessment
Company assessmentEmerging players
- Bioalternatives: French CRO specializing in in-vitro and ex-vivo skin biology testing for cosmetics and personal-care ingredients; adjacent capability overlap with Zurko's in-vitro lab at Albacete and offers an alternative for early-stage claim work.
- Tox Strategies: US-based toxicology and risk-assessment consulting firm providing regulatory toxicology support for cosmetic and consumer-product submissions; a partial overlap with Zurko's biocompatibility and regulatory service line.
Broad incumbents
- SGS: Swiss-listed TICx (testing, inspection, certification) major operating a Cosmetic & Personal Care practice with in-vivo safety, SPF, and clinical efficacy panels directly overlapping Zurko's core offering.
- Eurofins Product Testing: Global testing services giant with dedicated cosmetics and personal-care safety/efficacy labs across Europe and the US; competes with Zurko on clinical safety testing, HRIPT, SPF, and claims-substantiation work for CPG and beauty brands.
- Labcorp Drug Development (formerly Covance): Large CRO with preclinical safety assessment, clinical, and central-lab services; competes with Zurko for medical-device and consumer-product sponsors needing GLP-compliant toxicology and clinical work.
- Intertek: UK-listed testing group with a Cosmetics & Personal Care service line including HRIPT, RIPT, SPF/UVA, and clinical efficacy studies - a direct alternative for multinational CPG clients looking at EU/Spain-based lab capacity.
- Charles River Laboratories: Major safety-assessment CRO with global in-vivo and in-vitro toxicology capacity serving pharma, medical device, and consumer-products clients; overlaps with Zurko's biocompatibility (ISO 10993) and safety testing work.
Direct peers
- Complife Group: Italian-headquartered cosmetics and personal-care CRO offering in-vivo safety (HRIPT/RIPT), in-vitro testing, efficacy studies, and regulatory support - a near-direct Southern European peer to Zurko in the cosmetics testing niche.
- ProDerm GmbH: German dermatology CRO running standardized in-vivo efficacy and safety studies for cosmetics and personal-care manufacturers across Europe; competes with Zurko for German/DACH-based brand testing budgets.
- Dermscan Group: France-based clinical CRO specialized in cosmetic and dermatology efficacy/safety testing with patch-test panels, claim-substantiation studies, and CE/regulatory support - mirror of Zurko's clinical testing business in the French/EU market.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Zurko Research social profiles
Digital presenceZurko Research compliance and trust
Trust signalCompliance5 records
Zurko Research financial estimates
Financial estimateRevenue estimate
Valuation estimate
Zurko Research leadership team
Management profileNumber of profiles
Profiles3 records
Zurko Research subsidiaries and ownership
Company hierarchySubsidiaries2 records
Zurko Research funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Zurko Research M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Zurko Research
What does Zurko Research do?
Zurko Research is a Contract Research Organization (CRO) providing clinical testing and regulatory consultancy services for the cosmetics, medical devices, and biocides industries. Core offerings include in vivo and in vitro safety testing (HRIPT/RIPT, patch tests, challenge tests), clinical efficacy studies, preclinical biocompatibility testing per ISO 10993, and regulatory services covering CE marking, ISO 13485 quality systems, FDA submissions, and EU/international cosmetics compliance.
Is Zurko Research a public or private company?
Zurko Research is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Zurko Research founded?
Zurko Research was founded in 2005. It employs 51 to 100 people.
Where is Zurko Research based?
Zurko Research is headquartered in Madrid, Spain, in the Europe region.
How does Zurko Research make money?
Three revenue lines are on record. Clinical Testing Services are the primary driver. The others are regulatory Consulting and preclinical Testing.
Who are Zurko Research's main competitors?
Emerging players on record are Bioalternatives and Tox Strategies. Broad incumbents are SGS, Eurofins Product Testing, Labcorp Drug Development (formerly Covance), Intertek and Charles River Laboratories. Direct peers are Complife Group, ProDerm GmbH and Dermscan Group.
Does Zurko Research have an API?
No public API is recorded for Zurko Research.
What industry is Zurko Research in?
Zurko Research's product category is Contract Research Organization (CRO). Its primary akta.pro industry code is HLAGAAAC, Toxicology & Safety Assessment CROs (GLP), with a secondary code of HLAGAAAA, Clinical CROs (Phase I–IV). Its NAICS code is 5417 and its SIC code is 8731.